Share Name Share Symbol Market Type Share ISIN Share Description
Marlowe Plc LSE:MRL London Ordinary Share GB00BD8SLV43 ORD 50P
  Price Change % Change Share Price Shares Traded Last Trade
  7.00 0.83% 854.00 686,869 16:35:23
Bid Price Offer Price High Price Low Price Open Price
856.00 860.00 858.00 850.00 854.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 192.00 -1.60 -3.10 659
Last Trade Time Trade Type Trade Size Trade Price Currency
17:06:30 O 55,000 857.00 GBX

Marlowe (MRL) Latest News (9)

More Marlowe News
Marlowe Investors    Marlowe Takeover Rumours

Marlowe (MRL) Discussions and Chat

Marlowe Forums and Chat

Date Time Title Posts
10/5/202109:01Marlowe, a leading specialist compliance services group16
04/10/202010:20everyone MUST READ!106
10/9/200810:13Medoro with Charts & News33
20/7/200715:58 Medoro Resources > recovery thread1,945
18/4/200708:19are the shares ever going to go fucking up225

Add a New Thread

Marlowe (MRL) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-06-23 16:15:00857.0055,000471,350.00O
2021-06-23 16:15:00851.0075,000638,250.00O
2021-06-23 16:15:00851.0025,000212,750.00O
2021-06-23 16:15:00856.0046,856401,087.36O
2021-06-23 16:15:00855.0025,000213,750.00O
View all Marlowe trades in real-time

Marlowe (MRL) Top Chat Posts

Marlowe Daily Update: Marlowe Plc is listed in the General Financial sector of the London Stock Exchange with ticker MRL. The last closing price for Marlowe was 847p.
Marlowe Plc has a 4 week average price of 772p and a 12 week average price of 720p.
The 1 year high share price is 871p while the 1 year low share price is currently 478p.
There are currently 77,123,772 shares in issue and the average daily traded volume is 87,308 shares. The market capitalisation of Marlowe Plc is £658,637,012.88.
essential: Under the radar share this one. Scsw like it too
masurenguy: Marlowe growth plans to drive shares, says Berenberg Security systems provider Marlowe has set out ‘highly ambitious’ growth targets that Berenberg says could deliver serious upside. Analyst Calum Battersby reiterated his ‘buy’ recommendation and increased the target price from 660p to 900p. The company has announced targets over the next 3 years, including hitting £500m of revenue and £100m of earnings to be achieved ‘through a combination of 7% of organic growth per annum, 20% margins, 90% cash conversion and continuation of the group’s existing M&A strategy’, according to Battersby. ‘While clearly an aggressive target, we believe this can be achieved, given the company’s track record to date, and the scale of opportunities that already exist in its various end-markets,’ he said.
masurenguy: 28 October 2020 Marlowe plc Acquisition of Ellis Whittam (Holdings) Limited Marlowe plc, the specialist services group focused on developing companies which assure safety and regulatory compliance, announces that it has entered into a conditional agreement to acquire Ellis Whittam (Holdings) Ltd (together with its subsidiaries) for consideration of £59m on a cash-free, debt-free basis. Founded in 2004, Ellis Whittam is one of the UK's leading providers of outsourced Employment Law, HR and Health & Safety services. The company provides its services via a fixed-fee subscription model to over 3,300 organisations across the UK. It is headquartered in Chester, with offices in Glasgow and London, and employs approximately 180 staff, more than half of whom are health & safety consultants, employment lawyers and HR compliance advisors. Ellis Whittam's subscription-based advisory services help employers across the UK remain compliant with evolving employment law and health & safety legislation. The Group also announces a proposed placing to raise gross proceeds of up to £30m through the issue of up to 5,441,376 new ordinary shares of 50 pence each (the "Placing Shares") at 547p per share (the "Placing Price") to new and existing investors (the "Placing"). The Placing will be conducted by way of an accelerated bookbuild process which will be launched immediately in accordance with the terms and conditions set out in the Appendix to this Announcement. ........................................................................................................................................... . 29 October 2020 Marlowe plc Results of the Placing Further to the announcement of 28 October 2020 of the acquisition of Ellis Whittam and a proposed placing, Marlowe announces that it has successfully raised approximately £30m before expenses under the Placing, which was oversubscribed. The Placing Price of 547p per share represents a nil discount to the closing price on 28 October 2020. A total of 5,441,376 Placing Shares were placed with institutional investors, conditional on Admission. Pursuant to the Placing, the Group has raised net proceeds of approximately £29m after expenses. The issue of the Placing Shares is not subject to shareholder approval. Application has been made for the 5,441,376 Placing Shares to be admitted to trading on AIM, and it is expected that Admission will occur at 8.00 a.m. on or around 3 November 2020. Therefore, following Admission of the Placing Shares, the total number of Ordinary Shares with voting rights in the Group will be 60,266,796, which may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Group under the FCA's Disclosure Guidance and Transparency Rules.
dr biotech: Small company share watch. It’s a decent journal.
dr biotech: I bought these on the back of a share tip sheet. Its interesting to see the number of trades today so far is 34. Last week there were typically between 5-15 trades a day, gives an idea how many of us are reading and following this publication. I guess you'd have to look after a few days for a real figure. But I did notice this was marked up on opening to make sure we all paid a few quid extra.
masurenguy: Marlowe delivers compliance services across four individual and integrated divisions. Health & Safety, Fire Safety & Security, Air Testing & Quality and Water Treatment & Hygiene, utilising their own proprietary software platform. The business has developed using a buy & build strategy to establish a one-stop facility, which can be used by single site SME's as well as large multi-site companies. Marlowe was founded in mid-2015 by current CEO Alex Dacre and through organic growth and acquisition, it has become a leading specialist services group that provides safety and regulatory compliance. The company was originally formed out of a cash shell and backed by Lord Ashcroft. It is led by a Board of Directors with considerable experience in running large quoted and private businesses in the support services sector. It was admitted to AIM in April 2016. Marlowe operates in specialist, regulated markets and they provide services that are non-discretionary and generally insulated from changes in trends or the economy. The future growth of the business is underpinned by long-term drivers such as population growth, insurance requirements, reputational risk, urbanisation, increasing safety standards and increased digitalisation driving the need for more complex building systems and the consequences that this has for both maintenance & certification. Their service facilities address the increasingly broad and stringent health, safety and environmental regulations and the legal requirements to ensure that they are adopted and implemented. They operate in fragmented markets which can best be served by sourcing complementary bolt-on acquisitions that can be integrated, resulting in increased efficiency, cost-savings, broader capabilities and an expanding market share based on new revenue synergies that become available through effective intercompany collaboration. Their services are non-cyclical and they annually schedule over 1m service visits to audit, test, inspect, maintain & certify tens of thousands of properties and assets. Major Shareholders as at 30 September 2020 Lord Michael Ashcroft: 11,877,361. 23.54% Alex Dacre (CEO): 3,521,334. 6.97% Danske Capital Mgt: 3,116,184.00. 6.77% Canaccord Genuity Wealth Mgt: 2,499,783. 4.95% Royce & Associates: 1,872,506. 3.71% Majedie Asset Management: 1,421,095. 2.81% Columbia Threadneedle Investments: 1,388,011. 2.75% Total number of shares in issue: 50,455,989
daburd: Year end results due June (March year end). Market cap currently 145.6m. 2019 forecast 10.6m adjusted EDITDA, 2020 forecast 14m adjusted EBITDA. On a 20 multiple share price should be 5.19 now and 6.86 next year. On a 15 multiple 3.89 and 5.14 next year. I reckon this year may come in at 12m adjusted EBITDA which on a 15 or 20 multiple is an share price of 4.41 or 5.88. Whichever, today's price of 3.57 is significantly undervaluing Marlowe
firtashia: Yes, FY19 rev forecasts increased to £97m & FY19 forecast PBT up to £7m. I like buying relatively illiquid stocks when the business is doing well, the share price moves like sh*t off a shovel.
nfs: It was at the bottom of their company analysis section. Comments were short but raising 10m for more deals and investors were happy to finance this,share price up 70% in recent months
firtashia: Nice to see more significant director dealings today- wish I could buy in at the placing price as opposed to paying top whack. But never mind, there's only one reason that they're buying.......
Marlowe share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210624 04:09:56